Epithelial tumor suppressor deletion promotes neuroendocrine differentiation in bladder cancer and reveals homoharringtonine as a candidate vulnerability.

Synribo (omacetaxine mepesuccinate) - Teva

http://www.ncbi.nlm.nih.gov/pubmed/42749760

Bo Liu; Di Jin; Guanglei Zhuang; Haige Chen; Lei Qian; Qi Wang; Ruiyun Zhang; Siqi Wang; Tianxiang Zhang; Weiwei Zhang; Yuchen Wu

Sep 17, 2026